Filing Details
- Accession Number:
- 0001209191-19-037204
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-14 17:22:57
- Reporting Period:
- 2019-04-12
- Accepted Time:
- 2019-06-14 17:22:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-04-12 | 116 | $6.30 | 158,012 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-17 | 108 | $6.18 | 158,120 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-24 | 43 | $6.02 | 158,163 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-25 | 30 | $6.12 | 158,193 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-26 | 20 | $6.20 | 158,213 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-04-30 | 36 | $6.22 | 158,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-02 | 97 | $5.57 | 158,346 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-06 | 56 | $6.26 | 158,402 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-07 | 25 | $6.05 | 158,427 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-08 | 72 | $6.33 | 158,499 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-10 | 76 | $5.99 | 158,575 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-14 | 49 | $5.59 | 158,624 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-17 | 148 | $6.19 | 158,772 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-20 | 65 | $6.89 | 158,837 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-21 | 65 | $6.70 | 158,902 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-22 | 65 | $6.57 | 158,967 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-23 | 65 | $6.52 | 159,032 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-24 | 65 | $6.66 | 159,097 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-28 | 65 | $6.64 | 159,162 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-29 | 65 | $6.52 | 159,227 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-30 | 65 | $6.58 | 159,292 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-05-31 | 65 | $6.56 | 159,357 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-03 | 65 | $6.49 | 159,422 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-04 | 65 | $6.59 | 159,487 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-05 | 55 | $6.66 | 159,542 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-06 | 65 | $6.37 | 159,607 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-07 | 65 | $6.06 | 159,672 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-10 | 65 | $6.08 | 159,737 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-11 | 65 | $6.32 | 159,802 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-06-12 | 65 | $6.28 | 159,867 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.